AAAAAA

   
Results: 1-25 | 26-50 | 51-75 | 76-94
Results: 1-25/94
DESFERRIOXAMINE IMPROVES BURST-FORMING UNIT-ERYTHROID (BFU-E) PROLIFERATION IN HEMODIALYSIS-PATIENTS
Authors: AUCELLA F VIGILANTE M SCALZULLI P MUSTO P CRISETTI A MODONI S CAROTENUTO M STALLONE C
Citation: F. Aucella et al., DESFERRIOXAMINE IMPROVES BURST-FORMING UNIT-ERYTHROID (BFU-E) PROLIFERATION IN HEMODIALYSIS-PATIENTS, Nephrology, dialysis, transplantation, 13(5), 1998, pp. 1194-1199
SYMPTOMATIC MYOPATHY DURING INTERFERON-ALPHA THERAPY FOR CHRONIC MYELOGENOUS LEUKEMIA
Authors: FALCONE A BODENIZZA CA MUSTO P CAROTENUTO M
Citation: A. Falcone et al., SYMPTOMATIC MYOPATHY DURING INTERFERON-ALPHA THERAPY FOR CHRONIC MYELOGENOUS LEUKEMIA, Leukemia, 12(8), 1998, pp. 1329-1329
EFFICACY OF 2 DIFFERENT PROMACE-CYTABOM DERIVED REGIMENS IN ADVANCED AGGRESSIVE NON-HODGKINS-LYMPHOMA - FINAL REPORT OF A MULTICENTER TRIALCONDUCTED BY GISL
Authors: FEDERICO M CLO V BURGIATELLI M CAROTENUTO M GOBBI PG VALLISA D LOMBARDO M AVANZINI P DIRENZO N DINI D BALDINI L SILINGARDI V
Citation: M. Federico et al., EFFICACY OF 2 DIFFERENT PROMACE-CYTABOM DERIVED REGIMENS IN ADVANCED AGGRESSIVE NON-HODGKINS-LYMPHOMA - FINAL REPORT OF A MULTICENTER TRIALCONDUCTED BY GISL, Haematologica, 83(9), 1998, pp. 800-811
THY-1 (CDW90) AND C-KIT RECEPTOR (CD117) EXPRESSION ON CD34(- A 5-DIMENSIONAL FLOW CYTOMETRIC STUDY() HEMATOPOIETIC PROGENITOR CELLS )
Authors: DARENA G MUSTO P CASCAVILLA N CAROTENUTO M
Citation: G. Darena et al., THY-1 (CDW90) AND C-KIT RECEPTOR (CD117) EXPRESSION ON CD34(- A 5-DIMENSIONAL FLOW CYTOMETRIC STUDY() HEMATOPOIETIC PROGENITOR CELLS ), Haematologica, 83(7), 1998, pp. 587-592
EFFECT OF CYCLOSPORINE-A ON ANEMIA IN IDIOPATHIC MYELOFIBROSIS
Authors: FALCONE A MUSTO P CAROTENUTO M
Citation: A. Falcone et al., EFFECT OF CYCLOSPORINE-A ON ANEMIA IN IDIOPATHIC MYELOFIBROSIS, Haematologica, 83(7), 1998, pp. 665-666
CD117 (C-KIT) IS A RESTRICTED ANTIGEN OF ACUTE MYELOID-LEUKEMIA AND CHARACTERIZES EARLY DIFFERENTIATIVE LEVELS OF M5 FAB SUBTYPE
Authors: CASCAVILLA N MUSTO P DARENA G MELILLO L CARELLA AM PETRILLI MP SANPAOLO G CAROTENUTO M
Citation: N. Cascavilla et al., CD117 (C-KIT) IS A RESTRICTED ANTIGEN OF ACUTE MYELOID-LEUKEMIA AND CHARACTERIZES EARLY DIFFERENTIATIVE LEVELS OF M5 FAB SUBTYPE, Haematologica, 83(5), 1998, pp. 392-397
FLOW CYTOMETRIC CHARACTERIZATION OF HUMAN UMBILICAL-CORD BLOOD-LYMPHOCYTES - IMMUNOPHENOTYPIC FEATURES
Authors: DARENA G MUSTO P CASCAVILLA N DIGIORGIO G FUSILLI S ZENDOLI F CAROTENUTO M
Citation: G. Darena et al., FLOW CYTOMETRIC CHARACTERIZATION OF HUMAN UMBILICAL-CORD BLOOD-LYMPHOCYTES - IMMUNOPHENOTYPIC FEATURES, Haematologica, 83(3), 1998, pp. 197-203
MORE ON THE APPROPRIATE FLUOROCHROME-CONJUGATED CD34 ANTIBODY CHOICE FOR THE FLOW CYTOMETRIC DETECTION OF CIRCULATING PROGENITOR CELLS
Authors: DARENA G CAROTENUTO M
Citation: G. Darena et M. Carotenuto, MORE ON THE APPROPRIATE FLUOROCHROME-CONJUGATED CD34 ANTIBODY CHOICE FOR THE FLOW CYTOMETRIC DETECTION OF CIRCULATING PROGENITOR CELLS, Haematologica, 83(1), 1998, pp. 93-94
PREDICTIVE PARAMETERS FOR MOBILIZED PERIPHERAL-BLOOD CD34-CELL COLLECTION IN PATIENTS WITH HEMATOLOGICAL MALIGNANCIES( PROGENITOR)
Authors: DARENA G MUSTO P DIMAURO L CASCAVILLA N DELLOIACONO N SCALZULLI PR MATERA R CAROTENUTO M
Citation: G. Darena et al., PREDICTIVE PARAMETERS FOR MOBILIZED PERIPHERAL-BLOOD CD34-CELL COLLECTION IN PATIENTS WITH HEMATOLOGICAL MALIGNANCIES( PROGENITOR), American journal of hematology, 58(4), 1998, pp. 255-262
LONG-TERM ADMINISTRATION OF G-CSF DOES NOT INCREASE AT 5 YEARS THE RISK OF CYTOGENETIC ABNORMALITIES IN PATIENTS WITH SEVERE APLASTIC-ANEMIA
Authors: BACIGALUPO A BROCCIA G CORDA G ARCESE W DIBONA E CAROTENUTO M GALLAMINI A LOCATELLI F MORI P SARACCO P TODESCHINI G COSER P IACOPINO P VANLINT MT
Citation: A. Bacigalupo et al., LONG-TERM ADMINISTRATION OF G-CSF DOES NOT INCREASE AT 5 YEARS THE RISK OF CYTOGENETIC ABNORMALITIES IN PATIENTS WITH SEVERE APLASTIC-ANEMIA, Experimental hematology, 26(8), 1998, pp. 235-235
CIRCULATING CD34(-PARAMETER TO PREDICT THE QUALITY OF LEUKAPHERETIC YIELD() ABSOLUTE CELL NUMBER IS THE BEST SINGLE)
Authors: DARENA G MUSTO P CASCAVILLA N SCALZULLI PR DELLOIACONO N CAROTENUTO M
Citation: G. Darena et al., CIRCULATING CD34(-PARAMETER TO PREDICT THE QUALITY OF LEUKAPHERETIC YIELD() ABSOLUTE CELL NUMBER IS THE BEST SINGLE), Bone marrow transplantation, 22(2), 1998, pp. 215-216
SINGLE INSTITUTION EXPERIENCE ON THE EFFICACY OF TOTAL-BODY IRRADIATION (TBI) AND CHEMOTHERAPY AS CONDITIONING REGIMEN IN AUTOLOGOUS BMT FOR ANLL PATIENTS
Authors: CARELLA AM GRECO MM SAIEVA MR LADOGANA S CASCAVILLA N MELILLO L CAROTENUTO M
Citation: Am. Carella et al., SINGLE INSTITUTION EXPERIENCE ON THE EFFICACY OF TOTAL-BODY IRRADIATION (TBI) AND CHEMOTHERAPY AS CONDITIONING REGIMEN IN AUTOLOGOUS BMT FOR ANLL PATIENTS, Bone marrow transplantation, 21, 1998, pp. 334-334
PERIPHERAL-BLOOD STEM-CELL TRANSPLANTATION (PBSCT) IN PATIENTS WITH MULTIPLE-MYELOMA (MM) AT DIAGNOSIS - CAUSES OF PRETRANSPLANT FAILURE
Authors: MUSTO P GRECO M SAJEVA M FALCONE A BODENIZZA C CAROTENUTO M
Citation: P. Musto et al., PERIPHERAL-BLOOD STEM-CELL TRANSPLANTATION (PBSCT) IN PATIENTS WITH MULTIPLE-MYELOMA (MM) AT DIAGNOSIS - CAUSES OF PRETRANSPLANT FAILURE, Bone marrow transplantation, 21, 1998, pp. 697-697
PCR MONITORING OF MINIMAL RESIDUAL DISEASE IN ACUTE MYELOID-LEUKEMIA EXPRESSING AML1 ETO OR CBFB/MYH11 FUSION TRANSCRIPT/
Authors: MELILLO LMA SAGLIO G MINERVINI MM GOTTARDI E SERRA A CAROTENUTO M
Citation: Lma. Melillo et al., PCR MONITORING OF MINIMAL RESIDUAL DISEASE IN ACUTE MYELOID-LEUKEMIA EXPRESSING AML1 ETO OR CBFB/MYH11 FUSION TRANSCRIPT/, British Journal of Haematology, 102(1), 1998, pp. 99-99
RELIABILITY OF CD117 ANTIGEN EXPRESSION IN CHARACTERIZING EARLY DIFFERENTIATIVE LEVELS OF THE MONOCYTIC ACUTE LEUKEMIAS
Authors: CASCAVILLA N MUSTO P DARENA G GRECO MM MELILLO L CARELLA AM SAJEVA MR CAROTENUTO M
Citation: N. Cascavilla et al., RELIABILITY OF CD117 ANTIGEN EXPRESSION IN CHARACTERIZING EARLY DIFFERENTIATIVE LEVELS OF THE MONOCYTIC ACUTE LEUKEMIAS, British Journal of Haematology, 102(1), 1998, pp. 102-102
PROGNOSTICS FACTORS IN LOW (LG) AND INTERMEDIATE GRADE (IG) NON-HODGKINS-LYMPHOMAS (NHL) - RESULTS OF AN ANALYSIS PERFORMED IN 230 PATIENTS(PTS) TREATED WITH MBACOD
Authors: GUARINI A PAVONE V MELE A DECANTIS S CAROTENUTO M COLUCCI G MONACO M LISO V
Citation: A. Guarini et al., PROGNOSTICS FACTORS IN LOW (LG) AND INTERMEDIATE GRADE (IG) NON-HODGKINS-LYMPHOMAS (NHL) - RESULTS OF AN ANALYSIS PERFORMED IN 230 PATIENTS(PTS) TREATED WITH MBACOD, British Journal of Haematology, 102(1), 1998, pp. 130-131
FLAG REGIMEN IN POOR-RISK ACUTE MYELOID-LEUKEMIA
Authors: CARELLA AM GRECO M CASCAVILLA N LADOGANA S MELILLO L PERLA G SAJEVA MR CAROTENUTO M
Citation: Am. Carella et al., FLAG REGIMEN IN POOR-RISK ACUTE MYELOID-LEUKEMIA, British Journal of Haematology, 102(1), 1998, pp. 221-221
DIAGNOSTIC-SIGNIFICANCE OF SPONTANEOUS MEGAKARYOCYTIC (S-CFU-MK) AND ERYTHROID (S-BFU-E) COLONIES IN ESSENTIAL THROMBOCYTHEMIA (ET) AND IDENTIFICATION OF A NEW, MIXED MEGAKARYOCYTIC ERYTHROID HEMATOPOIETIC PROGENITOR/
Authors: SCALZULLI PR MORELLI A NOBILE M MANTUANO FS MATERA R MUSTO P CAROTENUTO M
Citation: Pr. Scalzulli et al., DIAGNOSTIC-SIGNIFICANCE OF SPONTANEOUS MEGAKARYOCYTIC (S-CFU-MK) AND ERYTHROID (S-BFU-E) COLONIES IN ESSENTIAL THROMBOCYTHEMIA (ET) AND IDENTIFICATION OF A NEW, MIXED MEGAKARYOCYTIC ERYTHROID HEMATOPOIETIC PROGENITOR/, British Journal of Haematology, 102(1), 1998, pp. 308-308
RECOMBINANT-HUMAN-ERYTHROPOIETIN FOR THE TREATMENT OF ANEMIA IN IDIOPATHIC MYELOFIBROSIS
Authors: FALCONE A MUSTO P BODENIZZA C CAROTENUTO M
Citation: A. Falcone et al., RECOMBINANT-HUMAN-ERYTHROPOIETIN FOR THE TREATMENT OF ANEMIA IN IDIOPATHIC MYELOFIBROSIS, British Journal of Haematology, 102(1), 1998, pp. 336-336
SERUM LEVELS OF CYTOKINES WITH HEMATOPOIETIC ACTIVITY IN MYELODYSPLASTIC SYNDROMES (MDS)
Authors: MUSTO P SANPAOLO G DARENA G MATERA R MINERVIVI M CAROTENUTO M
Citation: P. Musto et al., SERUM LEVELS OF CYTOKINES WITH HEMATOPOIETIC ACTIVITY IN MYELODYSPLASTIC SYNDROMES (MDS), British Journal of Haematology, 102(1), 1998, pp. 343-343
LONG-TERM RESULTS FROM MOPPEBVCAD CHEMOTHERAPY WITH OPTIONAL LIMITED RADIOTHERAPY IN ADVANCED HODGKINS-DISEASE
Authors: GOBBI PG PIERESCA C GHIRARDELLI ML DIRENZO N FEDERICO M MERIL F IANNITTO E PITINI V GRIGNANI G DONELLI A CAROTENUTO M SILINGARDI V
Citation: Pg. Gobbi et al., LONG-TERM RESULTS FROM MOPPEBVCAD CHEMOTHERAPY WITH OPTIONAL LIMITED RADIOTHERAPY IN ADVANCED HODGKINS-DISEASE, Blood, 91(8), 1998, pp. 2704-2712
SERUM LEVEL OF THE SOLUBLE FORM OF THE CD30 MOLECULE IDENTIFIES PATIENTS WITH HODGKINS-DISEASE AT HIGH-RISK OF UNFAVORABLE OUTCOME
Authors: NADALI G TAVECCHIA L ZANOLIN E BONFANTE V VIVIANI S CAMERINI E MUSTO P DIRENZO N CAROTENUTO M CHILOSI M KRAMPERA M PIZZOLO G
Citation: G. Nadali et al., SERUM LEVEL OF THE SOLUBLE FORM OF THE CD30 MOLECULE IDENTIFIES PATIENTS WITH HODGKINS-DISEASE AT HIGH-RISK OF UNFAVORABLE OUTCOME, Blood, 91(8), 1998, pp. 3011-3016
CLINICAL-RESULTS OF RECOMBINANT ERYTHROPOIETIN IN TRANSFUSION-DEPENDENT PATIENTS WITH REFRACTORY MULTIPLE-MYELOMA - ROLE OF CYTOKINES AND MONITORING OF ERYTHROPOIESIS
Authors: MUSTO P FALCONE A DARENA G SCALZULLI PR MATERA R MINERVINI MM LOMBARDI GF MODONI S LONGO A CAROTENUTO M
Citation: P. Musto et al., CLINICAL-RESULTS OF RECOMBINANT ERYTHROPOIETIN IN TRANSFUSION-DEPENDENT PATIENTS WITH REFRACTORY MULTIPLE-MYELOMA - ROLE OF CYTOKINES AND MONITORING OF ERYTHROPOIESIS, European journal of haematology, 58(5), 1997, pp. 314-319
NORMAL G-CSF-MOBILIZED CD34-BLOOD STEM-CELLS IN PAROXYSMAL-NOCTURNAL HEMOGLOBINURIA - A PERSPECTIVE FOR AUTOLOGOUS TRANSPLANTATION( PERIPHERAL)
Authors: MUSTO P DARENA G CASCAVILLA N CAROTENUTO M
Citation: P. Musto et al., NORMAL G-CSF-MOBILIZED CD34-BLOOD STEM-CELLS IN PAROXYSMAL-NOCTURNAL HEMOGLOBINURIA - A PERSPECTIVE FOR AUTOLOGOUS TRANSPLANTATION( PERIPHERAL), Leukemia, 11(6), 1997, pp. 890-892
ACUTE MYELOID-LEUKEMIA FOLLOWING 3M (MITOXANTRONE, MITOMYCIN AND METHOTREXATE) CHEMOTHERAPY FOR ADVANCED BREAST-CANCER
Authors: MELILLO LMA SAJEVA MR MUSTO P PERLA G CASCAVILLA N MINERVINI MM DARENA G CAROTENUTO M
Citation: Lma. Melillo et al., ACUTE MYELOID-LEUKEMIA FOLLOWING 3M (MITOXANTRONE, MITOMYCIN AND METHOTREXATE) CHEMOTHERAPY FOR ADVANCED BREAST-CANCER, Leukemia, 11(12), 1997, pp. 2211-2213
Risultati: 1-25 | 26-50 | 51-75 | 76-94